Tuberculosis (TB)
Tuberculosis (TB)
Tuberculosis or "TB" is a preventable and curable disease. It is caused by a bacterium (germ) called Mycobacterium tuberculosis. TB usually affects the lungs but it can also affect other parts of the body, including the glands, the bones and rarely the brain.
Guidance
National Tuberculosis Guidelines for Ireland
The New National Tuberculosis (TB) Guidelines for Ireland are currently being developed by an expert Guideline Development Group in collaboration with the Research and Guideline Development Unit (RGDU).
Importantly for your urgent attention, some of the terminology for TB is changing in these new national guidelines. In the latest chapters, Latent TB is now known as ‘TB infection,’ while Active TB is referred to as ‘TB disease.’ These and any other changes to terminology within the chapters are in line with updated guidelines published by the World Health Organization (WHO.)
The new guidelines will be published by individual chapter, in a phased approach. This is to support clinicians having the most timely information for action, as quickly as it is available. The new content and recommendations will supersede that of the previous Guidelines on the Prevention and Control of Tuberculosis in Ireland, 2010 - Amended 2014 as they are published.
Issues in relation to specific groups, e.g. underserved populations, will be dealt with at a later stage in the process.
Chapter 1: Introduction
25, Jun 2025
425.02 KB
Chapter 2: Diagnosing and Managing TB Infection
Formerly known as 'latent TB.'
25, Jun 2025
327.31 KB
Chapter 3: TB Disease
Formerly known as 'active TB.'
23, Jun 2025
372.18 KB
Chapter 4: Treatment of Cases with Drug-Resistant TB (DR-TB)
23, Jun 2025
336.91 KB
National Tuberculosis Guidelines for Ireland - Chapter 5: Laboratory Diagnosis of Mycobacterium tuberculosis Disease
22, Jul 2026
689.7 KB
Chapter 6: TB in Children and Adolescents
20, Mar 2025
275.63 KB
Chapter 7: Contact Tracing and Case Finding
19, May 2025
377.04 KB
Chapter 8: Infection Prevention and Control
12, Mar 2026
479.95 KB
Chapter 10: Adherence, Treatment Completion and Follow-up
18, Nov 2025
321.74 KB
Appendix I: Tuberculin Skin Testing Contraindications, Administration and Interpretation
23, Dec 2024
241.81 KB
***UNDER REVIEW*** Guidelines on the Prevention and Control of Tuberculosis in Ireland, 2010 - Amended 2014
Chapter 9: Screening in special situations
01, Jan 2014
433.62 KB
Chapter 10: TB and HIV infection
01, Jan 2014
115.6 KB
Case definition
Tuberculosis (Mycobacterium tuberculosis complex)
Clinical criteria
Any person with the following two:
- Signs, symptoms and/or radiological findings consistent with active tuberculosis in any site
AND
- A clinician’s decision to treat the person with a full course of anti-tuberculosis therapy
OR
A case discovered post-mortem with pathological findings consistent with active tuberculosis that would have indicated anti-tuberculosis antibiotic treatment had the patient been diagnosed before dying
Laboratory criteria
- Laboratory criteria for a confirmed case
At least one of the following two:
- Isolation of Mycobacterium tuberculosis complex (excluding Mycobacterium bovis-BCG) from a clinical specimen
- Detection of Mycobacterium tuberculosis complex nucleic acid in a clinical specimen AND positive microscopy for acid-fast bacilli or equivalent fluorescent staining bacilli on light microscopy
- Laboratory criteria for a probable case
At least one of the following three:
- Microscopy for acid-fast bacilli or equivalent fluorescent staining bacilli on light microscopy
- Detection of Mycobacterium tuberculosis complex nucleic acid in a clinical specimen
- Histological appearance of granulomata
Epidemiological criteria
NA
Case classification
A. Possible case
Any person meeting the clinical criteria
B. Probable case
Any person meeting the clinical criteria and the laboratory criteria for a probable case
C. Confirmed case
Any person meeting the clinical and the laboratory criteria for case confirmation
Current as of: 24 January 2019